Medicare Negotiations: Industry Makes Headway At Appeals Court With First Amendment Argument

Judges on the Third Circuit panel in the BMS and JNJ IRA cases seemed sympathetic to industry’s concerns about the government using the term “maximum fair price” in the IRA’s Medicare drug price negotiation program.